Royalty Pharma plc - Ordinary Shares - Class A Latest Ownership Pattern - Insider, Institutional, Mutual Fund shareholdings

Royalty Pharma plc - Ordinary Shares - Class A XNAS: RPRX

Strong Performer, Under Radar

35.68 -0.38 (-1.05%)

547.5K

XNAS Volume

XNAS 28 Aug, 2025 12:14 PM (EDT)

Acquisition

Royalty Pharma to acquire 7% royalty in Amgen's lung cancer drug Imdelltra for $950 million See details